Search product dossiers, aliases, quality checks and buying guides. Content is educational and does not replace approved product information or medical advice.
SURMOUNT-5 compared tirzepatide and semaglutide directly. Here is what was measured, the results, the side-effect picture and what the numbers do not tell you.
Draft pending editorial review
What retatrutide is, how it differs from semaglutide and tirzepatide, what the TRIUMPH trials reported in 2025–2026, and why it is still not an approved medicine.
Draft pending editorial review
Peptides are short chains of amino acids. This guide explains what they are, how they differ from proteins, which peptide medicines are approved and why 'research peptide' is a different category.
Draft pending editorial review
BPC-157 is one of the most searched peptides. This article separates animal data from human evidence, and explains its FDA, compounding and anti-doping status.
Draft pending editorial review
GHK-Cu is a naturally occurring copper-binding tripeptide used in skincare. What the research shows for skin, where the evidence is thin, and how topical and injectable use differ.
Draft pending editorial review
NAD+ is a coenzyme central to cell energy. Here is what the human evidence says about NAD+ infusions, NMN and NR, and which claims are still unproven.
Draft pending editorial review
Two peptides linked to mitochondria with very different evidence: MOTS-c is mostly preclinical, while SS-31 became an FDA-approved medicine for Barth syndrome in 2025.
Draft pending editorial review